Do you want to read an article? Please log in or register.
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B
Hepatitis
RECOMMENDED
Related content
RECOMMENDED
Hepatitis
Technical systematic review supporting 2025 AASLD Practice Guidelines on management of chronic hepatitis B
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Hepatology
Pan CQ, Saadi S, Ghany MG, Feld JJ, Lim JK, Kim AY, Tang AS, Nguyen MH, Sulkowski MS, Terrault NA, Lok AS, Hegazi M, Hasan B, Fleti F, Nayfeh T, Abusalih MF, Seisa MO, Kabbara Allababidi A, Abbas AS, Prokop LJ, Murad MH, Mohammad KS
doi: 10.1097/HEP.0000000000001584
Hepatitis
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study
Am J Gastroenterol
Li J, Liu JK, Chau A, Linden S, Tsai PC, Nozaki A, Vutien P, Uojima H, Toyoda H, Honda T, Trinh H, Abe H, Ishikawa T, Atsukawa M, Watanabe T, Tsuji K, Huang DQ, Takaguchi K, Itobayashi E, Marciano S, Rui F, Ni W, Takahashi H, Chuang WL, Dai CY, Huang JF, Huang CF, Yeh ML, Zhu Y, Itokawa N, Kozuka R, Inoue K, Senoh T, Maeda M, Ito T, Morimoto M, Cheung R, Gadano A, Enomoto M, Tanaka Y, Lim SG, Wu C, Yu ML, Nguyen MH
doi: 10.14309/ajg.0000000000003881
Hepatitis
Early treatment initiation optimizes virologic and liver outcomes in pediatric patients with chronic hepatitis B aged 0-18 years
Clin Gastroenterol Hepatol
Chen L, Jiang L, Zhao B, Jiang Y, Liu S, Li M, Li Y, Jiang Y, Li M, Wei H, Bao C, Niu J, Zhao J
doi: 10.1016/j.cgh.2026.01.026
Hepatitis
Single nucleotide polymorphisms in the bepirovirsen binding site have limited impact on treatment response in chronic hepatitis B
J Hepatol
Bouquet J, Speer SD, Koenig A, Livingston CM, Savarese M, Lau C, Angelini E, Galwey N, Yates P, Maynard L, You S, Cremer J, Paff M, Theodore D, Elston R, Walker J
doi: 10.1016/j.jhep.2025.12.025
Hepatitis
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort
J Hepatol
Dongelmans E, Hirode G, van Bӧmmel F, Jeng WJ, Chien RN, Chen CH, Kilany M, Su TH, Kao JH, Seto WK, Liang LY, Reikvam DH, Holmberg M, Furquim d'Almeida A, Papatheodoridi M, Maasoumy B, Hansen B, Post R, Pocurull A, Terrault N, Ghany M, Johannessen A, Lok A, Vanwolleghem T, Lens S, Cornberg M, Yuen MF, Wong G, Sonneveld M, Papatheodoridis G, Berg T, Hsu YC, Feld J, Janssen H, RETRACT-B study group
doi: 10.1016/j.jhep.2026.03.030
Hepatitis
Effectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B patients with low-level viremia: a retrospective real-world study
BMC Gastroenterol
Qiu X, Yin Y, Zhang S, Liu W
doi: 10.1186/s12876-026-04830-5
Hepatology
AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation
Hepatology
Martinez M, Adeyemi A, Chu J, Costandi A, Foca MD, Griesemer AD, Gupta NA, Hsu EK, Mazariegos GV, Plevinsky JM, Wadhwani SI, Ng VL
doi: 10.1097/HEP.0000000000001805
Hepatitis
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection
Gut
Tang S, Huang T, Tang R, Lin K, Luo C, Shen Y, Zhang K, Tang Y, Kong J, Chen Z, Fu J, Lin Q, Guo L, Wu Y, Li Y, Zhang J, Sun Z, You P, Zhang D, Chen Y, Lin X, Zhong C, Lin Z, Liu H, Huang Z, Zhou W, Dong P, Liu X, Zeng H, Qi X, Zeng Y
doi: 10.1136/gutjnl-2025-335449
Hepatology
AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation
Hepatology
Dove L, Chadha RM, Lai JC, DiMartini A, Liapakis A, Parikh N, Firpi-Morell R, Conteh L, Fallon M, Trotter J, Ladner D, Sapisochin G, Lucey M
doi: 10.1097/HEP.0000000000001644